SAMH
PTCT icon

Shanda Asset Management Holdings’s PTC Therapeutics PTCT Stock Holding History

Shanda Asset Management Holdings’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-30,332
Closed -$1.36M – 38
2019
Q2 		$1.36M Hold
30,332
– – 0.25% 16
2019
Q1 		$1.14M Hold
30,332
– – 0.18% 29
2018
Q4 		$1.04M Hold
30,332
– – 0.19% 35
2018
Q3 		$1.43M Hold
30,332
– – 0.23% 20
2018
Q2 		$1.02M Hold
30,332
– – 0.16% 31
2018
Q1 		$821K Hold
30,332
– – 0.13% 27
2017
Q4 		$506K Buy
+30,332
New +$513K 0.08% 39

Other funds holding PTCT

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Shanda Asset Management Holdings's PTCT Position: Q3 2019 in Review

Shanda Asset Management Holdings sold out of PTC Therapeutics (PTCT) in Q3 2019, closing a stake of 30,332 shares — an estimated $1.36M sold.

Shanda Asset Management Holdings first reported a position in PTCT in Q4 2017 and held it in 7 quarters. The position peaked at $1.43M in Q3 2018. 184 funds tracked by Wall St. Rank hold PTCT as of Q3 2019.

  • Shanda Asset Management Holdings reported no remaining PTC Therapeutics position as of Q3 2019 after selling out during the quarter.
  • Shanda Asset Management Holdings sold 30,332 PTC Therapeutics shares in Q3 2019, an estimated $1.36M.
  • Shanda Asset Management Holdings first reported a position in PTC Therapeutics in Q4 2017 and held it in 7 quarters.
  • Shanda Asset Management Holdings's PTC Therapeutics position peaked at $1.43M in Q3 2018.
  • 184 funds tracked by Wall St. Rank held PTC Therapeutics as of Q3 2019.

Based on Shanda Asset Management Holdings's 13F filing for Q3 2019, filed 14 Nov 2019.